Role of interleukin-6 transsignaling in multiple myeloma and therapeutic implications

被引:0
|
作者
Burger, R. [1 ]
Broeker, K. [1 ]
Kretschmar, F. [1 ]
Richter, K. [1 ]
Ahrens, T. [1 ]
Wijdenes, J. [2 ]
Rose-John, S. [3 ]
Scheller, J. [3 ]
Guenther, A. [1 ]
Gramatzki, M. [1 ]
机构
[1] Univ Kiel, Div Stem Cell Transplantat & Immunotherapy, Dept Med 2, Kiel, Germany
[2] Gen Probe Diaclone, Besancon, France
[3] Univ Kiel, Dept Biochem, Kiel, Germany
来源
ONKOLOGIE | 2010年 / 33卷
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:152 / 152
页数:1
相关论文
共 50 条
  • [31] PREDICTIVE VALUE OF INTERLEUKIN-6 AND NEOPTERIN IN PATIENTS WITH MULTIPLE-MYELOMA
    REIBNEGGER, G
    KRAINER, M
    HEROLD, M
    LUDWIG, H
    WACHTER, H
    HUBER, H
    CANCER RESEARCH, 1991, 51 (23) : 6250 - 6253
  • [32] The prognostic value of soluble interleukin-6 receptor in patients with multiple myeloma
    Stasi, R
    Brunetti, M
    Parma, A
    Di Giulio, C
    Terzoli, E
    Pagano, A
    CANCER, 1998, 82 (10) : 1860 - 1866
  • [33] Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
    Rosean, Timothy R.
    Tompkins, Van S.
    Tricot, Guido
    Holman, Carol J.
    Olivier, Alicia K.
    Zhan, Fenghuang
    Janz, Siegfried
    IMMUNOLOGIC RESEARCH, 2014, 59 (1-3) : 188 - 202
  • [34] Preclinical validation of interleukin 6 as a therapeutic target in multiple myeloma
    Timothy R. Rosean
    Van S. Tompkins
    Guido Tricot
    Carol J. Holman
    Alicia K. Olivier
    Fenghuang Zhan
    Siegfried Janz
    Immunologic Research, 2014, 59 : 188 - 202
  • [35] Interleukin-6 as a Therapeutic Target
    Rossi, Jean-Francois
    Lu, Zhao-Yang
    Jourdan, Michel
    Klein, Bernard
    CLINICAL CANCER RESEARCH, 2015, 21 (06) : 1248 - 1257
  • [36] Arsenic trioxide targets the interleukin-6 cascade in multiple myeloma by promoting lysosomal degradation of the interleukin-6 receptor complex.
    Cheung, WC
    Kwong, YL
    BLOOD, 2005, 106 (11) : 373B - 373B
  • [37] Characterization of interleukin-6 (IL-6) signal transduction in multiple myeloma (MM).
    Ogata, A
    Urashima, M
    Chauhan, D
    Anderson, K
    BLOOD, 1995, 86 (10) : 221 - 221
  • [38] Serum YKL-40 correlates with serum interleukin-6 in multiple myeloma
    Mylin, A. K.
    Andersen, N. F.
    Johansen, J. S.
    Abildgaard, N.
    Gimsing, P.
    Knudsen, L. M.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2007, 92 (06): : 115 - 115
  • [39] Autocrine growth regulation of circulating clonotypic B cells in human multiple myeloma - Interleukin-6 and interleukin-6 receptor expression.
    Szczepek, AJ
    Belch, AR
    Mant, MJ
    Pilarski, LM
    BLOOD, 1997, 90 (10) : 1566 - 1566
  • [40] Interleukin-6 Interweaves the Bone Marrow Microenvironment, Bone Loss, and Multiple Myeloma
    Harmer, Danielle
    Falank, Carolyne
    Reagan, Michaela R.
    FRONTIERS IN ENDOCRINOLOGY, 2019, 9